Transport of curcumin derivatives in Caco-2 cell monolayers

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 117, Issue , 2017, Pages 123-131

  Zeng, Zhen ^a   Shen, Zhe L ^a   Zhai, Shuo ^b   Xu, Jia L ^a   Liang, Hui ^a   Shen, Qin ^a   Li, Qing Y ^a  

^a ZHEJIANG UNIVERSITY OF TECHNOLOGY   (China)

^b Hangzhou No 2 High School of Zhejiang Province   (China)

Author keywords

Caco 2 cell monolayers; Curcumin derivatives; Intestinal permeability; Intestinal transport; Passive transport

Indexed keywords

1 (3,4 METHOXYPHENYL) 5 (4 HYDROXY 3,5 METHOXYPHENYL) 1,4 DIENE 3 PENTANONE; 1,5 BIS (3 METHOXY 4 HYDROXYPHENYL) 1,4 DIENE 3 PENTANONE; CURCUMIN; POLYPHENOL DERIVATIVE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT;

APICAL MEMBRANE; ARTICLE; BASOLATERAL MEMBRANE; CACO-2 CELL LINE; CONCENTRATION RESPONSE; DRUG BIOAVAILABILITY; DRUG TRANSPORT; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTESTINE ABSORPTION; INTESTINE MUCOSA PERMEABILITY; MONOLAYER CULTURE; PASSIVE TRANSPORT; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

ANTINEOPLASTIC AGENTS; BIOLOGICAL TRANSPORT; CACO-2 CELLS; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; CURCUMIN; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INTESTINAL ABSORPTION;

EID: 85017470681     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2017.04.004     Document Type: Article

References (36)

1. [1] Aggarwal, B.B., Kumar, A., Bharti, A.C., Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 23 (2003), 363–398.
2. [2] Jayaprakash, G.K., Rao, L.J., Gakariah, K.K., Antioxidant activities of curcumin, demethoxycurcumin and bisdemethoxycurcumin. Food Chem. 98 (2006), 720–724.
3. [3] Parvathy, K.S., Negi, P.S., Srinivas, P., Antioxidant, antimutagenic and antibacterial activities of curcumin-b-diglucoside. Food Chem. 115 (2009), 265–271.
4. [4] Wang, M.S., Boddapati, S., Emadi, S., Sierks, M.R., Curcumin reduces a-synuclein induced cytotoxicity in Parkinson's disease cell model. BMC Neurosci. 11 (2011), 57–66.
5. [5] Olszanecki, R., Jawień, J., Gajda, M., Mateuszuk, L., Gebska, A., Korabiowska, M., Effect of curcumin on atherosclerosis in apoE/LDLR-double knockout mice. J. Physiol. Pharmacol. 56 (2005), 627–635.
6. [6] Maheshwari, R.K., Singh, A.K., Gaddipati, J., Srimal, R.C., Multiple biological activities of curcumin: a short review. Life Sci. 78 (2006), 2081–2087.
7. [7] Baldwin, P.R., Reeves, A.Z., Powell, K.R., Napier, R.J., Swimm, A.I., Sun, A., Giesler, K., Bommarius, B., Shinnick, T.M., Snyder, J.P., Liotta, D.C., Kalman, D., Monocarbonyl analogs of curcumin inhibit growth of antibiotic sensitive and resistant strains of Mycobacterium tuberculosis. Eur. J. Med. Chem. 92 (2015), 693–699.
8. [8] Anand, P., Kunnumakkara, A.B., Newman, R.A., Aggarwal, B.B., Bioavailability of curcumin: problems and promises. Mol. Pharm. 4 (2007), 807–818.
9. [9] Marcolino, V.A., Zanin, G.M., Durrant, L.R., Benassi, M.D.T., Matioli, G., Interaction of curcumin and bixin with β-cyclodextrin: complexation methods, stability, and applications in food. J. Agric. Food Chem. 59 (2011), 3348–3357.
10. [10] Zou, L.Q., Liu, W., Liu, C.M., Xiao, H., McClements, D.J., Utilizing food matrix effects to enhance nutraceutical bioavailability: increase of curcumin bioaccessibility using excipient emulsions. J. Agric. Food Chem. 63 (2015), 2052–2062.
11. [11] Francesco, D., Wang, Y.W., Li, J., Huang, Q.R., Preparation of curcumin sub-micrometer dispersions by high-pressure homogenization. J. Agric. Food Chem. 58 (2010), 2848–2853.
12. [12] Yu, H.L., Huang, Q.R., Improving the oral bioavailability of curcumin using novel organogel-based nanoemulsions. J. Agric. Food Chem. 60 (2012), 5373–5379.
13. [13] Gangwar, R.K., Tomar, G.B., Dhumale, V.A., Zinjarde, S., Sharma, R.B., Datar, S., Curcumin conjugated silica nanoparticles for improving bioavailability and its anticancer applications. J. Agric. Food Chem. 61 (2013), 9632–9637.
14. [14] Zhu, H.P., Xu, T.T., Qiu, C.Y., Wu, B.B., Zhang, Y.L., Chen, L.F., Xia, Q.Q., Li, C.L., Zhou, B., Liu, Z.G., Liang, G., Synthesis and optimization of novel allylated mono-carbonyl analogs of curcumin (MACs) act as potent anti-inflammatory agents against LPS-induced acute lung injury (ALI) in rats. Eur. J. Med. Chem. 121 (2016), 181–193.
15. [15] Aluwi, M.F.F.M., Rullah, K., Yamin, B.M., Leong, S.W., Bahari, M.N.A., Lim, S.J., Faudzi, S.M.M., Jalil, J., Abas, F., Fauzi, N.M., Ismail, N.H., Jantan, I., Lam, K.W., Synthesis of unsymmetrical monocarbonyl curcumin analogues with potent inhibition on prostaglandin E2 production in LPS-induced murine and human macrophages cell lines. Bioorg. Med. Chem. Let. 26 (2016), 2531–2538.
16. [16] Chakraborti, S., Dhar, G., Dwivedi, V., Das, A., Poddar, A., Chakraborti, G., Basu, G., Chakrabarti, P., Surolia, A., Bhattacharyya, B., Stable and potent analogues derived from the modification of the dicarbonyl moiety of curcumin. Biochem. US 52 (2013), 7449–7460.
17. [17] Minassi, A., Sánchez-Duffhues, G., Collado, J.A., Muñoz, E., Appendino, G., Dissecting the pharmacophore of curcumin. Which structural element is critical for which action?. J. Nat. Prod. 76 (2013), 1105–1112.
18. [18] Li, C.R., Zhang, L., Zhou, L.M., Wo, S.K., Lin, G., Zuo, Z., Comparison of intestinal absorption and disposition of structurally similar bioactive flavones in Radix Scutellariae. AAPS J 14 (2012), 23–34.
19. [19] Maubon, N., Vee, M.L., Fossati, L., Audry, M., Ferrec, E.L., Bolze, S., Fardel, O., Analysis of drug transporter expression in human intestinal Caco-2 cells by real-time PCR. Fundam. Clin. Pharmacol. 21 (2007), 659–663.
20. [20] Artursson, P., Karlsson, J., Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun. 175 (1991), 880–885.
21. [21] Li, Q.Y., Chen, J., Luo, S.Y., Xu, J.L., Huang, Q.X., T.Y Liu, Synthesis and assessment of the antioxidant and antitumor properties of asymmetric curcumin analogues. Eur. J. Med. Chem. 93 (2015), 461–469.
22. [22] Sgouras, D., Duncan, R., Use of the tetrazolium-based colorimetric assay (MTT) as a preliminary screen for the evaluation of in vitro cytotoxicity. J. Mater. Sci. - Mater. Med. 1 (1990), 61–68.
23. [23] Hubatsch, I., Ragnarsson, E.G.E., Artursson, P., Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers. Nat. Protocols. 2 (2007), 2111–2119.
24. [24] Volpe, D.A., Faustino, P.J., Ciavarella, A.B., Asafu-Adjaye, E.B., Ellison, C.D., Yu, L.X., Hussain, A.S., Classification of drug permeability with a Caco-2 cell monolayer assay. Clin. Res. Reg. Affairs 24 (2007), 39–47.
25. [25] Artursson, P., Palm, K., Luthman, K., Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv. Drug Delivery Rev. 46 (2001), 27–43.
26. [26] Wahlstrom, B., Blennow, G., A study on the fate of curcumin in the rat. Acta Pharmacol. Toxicol. 43 (1978), 68–92.
27. [27] Anand, P., Sundaram, C., Jhurani, S., Kunnumakkara, A.B., Aggarwal, B.B., Curcumin and cancer: an “old-age” disease with an “age-old” solution. Cancer Lett. 267 (2008), 133–164.
28. [28] Marrink, S.J., 3/4hnig, F., Berendsen, H.J., et al. Proton transport across transient single 2 file water pores in a lipid membrane studied by molecular dynamics simulations. Biophys. J. 71 (1996), 632–647.
29. [29] Li, G.H., A review of oral drug absorption. Tianjin Pharm. 26 (2014), 69–71.
30. [30] Zhang, B., Zhu, X.M., Hu, J.N., Ye, H., Luo, T., Liu, X.R., Li, H.Y., Li, W., Zheng, Y.N., Deng, Z.Y., absorption mechanism of ginsenoside compound K and Its butyl and octyl ester prodrugs in Caco-2 cells. J. Agric. Food Chem. 60 (2012), 10278–10284.
31. [31] Wahlang, B., Pawar, Y.B., Bansal, A.K., Identification of permeability-related hurdles in oral delivery of curcumin using the Caco-2 cell model. Eur. J. Pharm. Biopharm. 77 (2011), 275–282.
32. [32] Hou, X.L., Takahashi, K., Tanaka, K., Tougou, K., Qiu, F., Komatsu, K., Takahashi, K., Azum, J., Curcuma drugs and curcumin regulate the expression and function of P-gp in Caco-2 cells in completely opposite ways. Int. J. Pharm. 358 (2008), 224–229.
33. [33] Antunes, F., Andrade, F., Ferreira, D., Nielsen, H.M., Sarmento, B., Models to predict intestinal absorption of therapeutic peptides and proteins. Curr. Drug Metab. 14 (2013), 4–20.
34. [34] Sun, H., Chow, E.C.Y., Liu, S., Du, Y., Pang, K.S., The Caco-2 cell monolayer: usefulness and limitations. Expert Opin. Drug Metab. Toxicol. 4 (2008), 395–411.
35. [35] Yu, H.L., Huang, Q.R., Investigation of the absorption mechanism of solubilized curcumin using Caco-2 cell monolayers. J. Agric. Food Chem. 59 (2011), 9120–9126.
36. [36] Wang, J.L., Ma, W.Z., Tu, P.F., The mechanism of self-assembled mixed micelles in improving curcumin oral absorption: in vitro and in vivo. Colloid. Surf. B 133 (2015), 108–119.